{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:59:35Z","timestamp":1789955975506,"version":"4.0.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.det.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T08:18:31Z","timestamp":1480061911000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Mosaic Disorders of the PI3K\/PTEN\/AKT\/TSC\/mTORC1 Signaling Pathway"],"prefix":"10.1016","volume":"35","author":[{"given":"Neera","family":"Nathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Keppler-Noreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie G.","family":"Biesecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Darling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2016.07.001_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrg3424","article-title":"A\u00a0genomic view of mosaicism and human disease","volume":"14","author":"Biesecker","year":"2013","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.det.2016.07.001_bib2","series-title":"Mosaicism in human skin understanding nevi, nevoid skin disorders, and cutaneous neoplasia","author":"Happle","year":"2013"},{"key":"10.1016\/j.det.2016.07.001_bib3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ajmg.a.37439","article-title":"The categories of cutaneous mosaicism: a proposed classification","volume":"170","author":"Happle","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.det.2016.07.001_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.det.2016.07.001_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ceb.2011.09.003","article-title":"mTOR signaling in disease","volume":"23","author":"Dazert","year":"2011","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.det.2016.07.001_bib6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.det.2016.07.001_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0370217","article-title":"A\u00a0complex interplay between Akt, TSC2 and the two mTOR complexes","volume":"37","author":"Huang","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.det.2016.07.001_bib8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archderm.140.8.947","article-title":"Cutaneous manifestations of proteus syndrome: correlations with general clinical severity","volume":"140","author":"Nguyen","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","article-title":"Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum","volume":"164","author":"Keppler-Noreuil","year":"2014","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.det.2016.07.001_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajmg.c.31364","article-title":"When overgrowth bumps into cancer: the PTEN-opathies","volume":"163C","author":"Mester","year":"2013","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.det.2016.07.001_bib11","doi-asserted-by":"crossref","first-page":"e1005637","DOI":"10.1371\/journal.pgen.1005637","article-title":"Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing","volume":"11","author":"Tyburczy","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.det.2016.07.001_bib12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-154-12-201106210-00008","article-title":"Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences","volume":"154","author":"Seibert","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.det.2016.07.001_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gde.2012.12.005","article-title":"mTOR in aging, metabolism, and cancer","volume":"23","author":"Cornu","year":"2013","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.det.2016.07.001_bib14","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1101\/gad.835000","article-title":"Regulation of cellular growth by the Drosophila target of rapamycin dTOR","volume":"14","author":"Zhang","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.det.2016.07.001_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.mrrev.2008.06.001","article-title":"The mTOR pathway and its role in human genetic diseases","volume":"659","author":"Rosner","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.det.2016.07.001_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/excr.2000.5130","article-title":"PTEN: life as a tumor suppressor","volume":"264","author":"Simpson","year":"2001","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.det.2016.07.001_bib17","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate","volume":"273","author":"Maehama","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.det.2016.07.001_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ncb999","article-title":"Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins","volume":"5","author":"Zhang","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.det.2016.07.001_bib19","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/gim.2013.51","article-title":"A\u00a0mosaic PTEN mutation causing Cowden syndrome identified by deep sequencing","volume":"15","author":"Pritchard","year":"2013","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.det.2016.07.001_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10689-014-9709-4","article-title":"Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome","volume":"13","author":"Salo-Mullen","year":"2014","journal-title":"Fam Cancer"},{"key":"10.1016\/j.det.2016.07.001_bib21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1365-2133.2007.07818.x","article-title":"Type 2 segmental Cowden disease vs. proteus syndrome","volume":"156","author":"Happle","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.ejhg.5201823","article-title":"Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity","volume":"15","author":"Caux","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.det.2016.07.001_bib23","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1086\/302412","article-title":"High rate of mosaicism in tuberous sclerosis complex","volume":"64","author":"Verhoef","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.det.2016.07.001_bib24","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1073\/pnas.0510857103","article-title":"Cancer-specific mutations in PIK3CA are oncogenic in\u00a0vivo","volume":"103","author":"Bader","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.det.2016.07.001_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9440(10)61714-2","article-title":"AKT1\/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells","volume":"159","author":"Sun","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.det.2016.07.001_bib26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1104017","article-title":"A\u00a0mosaic activating mutation in AKT1 associated with the Proteus syndrome","volume":"365","author":"Lindhurst","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2016.07.001_bib27","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.05.006","article-title":"Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome","volume":"90","author":"Kurek","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.det.2016.07.001_bib28","doi-asserted-by":"crossref","first-page":"17162","DOI":"10.1038\/srep17162","article-title":"Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome","volume":"5","author":"Lindhurst","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.det.2016.07.001_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2012.10.021","article-title":"Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes","volume":"92","author":"Orloff","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.det.2016.07.001_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.36836","article-title":"PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation","volume":"167A","author":"Keppler-Noreuil","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.det.2016.07.001_bib31","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1002\/ajmg.a.32023","article-title":"Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients","volume":"143A","author":"Sapp","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.det.2016.07.001_bib32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jaad.2004.12.047","article-title":"Evolution of skin lesions in Proteus syndrome","volume":"52","author":"Twede","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.hcl.2008.12.006","article-title":"Overgrowth conditions: a diagnostic and therapeutic conundrum","volume":"25","author":"Carty","year":"2009","journal-title":"Hand Clin"},{"key":"10.1016\/j.det.2016.07.001_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/2229-5178.131108","article-title":"Proteus syndrome: a rare cause of gigantic limb","volume":"5","author":"Chakrabarti","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.det.2016.07.001_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.01.016","article-title":"The group of epidermal nevus syndromes part II. Less well defined phenotypes","volume":"63","author":"Happle","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib36","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archderm.1993.01680320094012","article-title":"Mosaicism in human skin. Understanding the patterns and mechanisms","volume":"129","author":"Happle","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.ejhg.5201638","article-title":"The challenges of Proteus syndrome: diagnosis and management","volume":"14","author":"Biesecker","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.det.2016.07.001_bib38","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.0705218104","article-title":"Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern","volume":"104","author":"Hafner","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.det.2016.07.001_bib39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2133.2011.10788.x","article-title":"FGFR3, PIK3CA and RAS mutations in benign lichenoid keratosis","volume":"166","author":"Groesser","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib40","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA","volume":"166","author":"Luks","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.det.2016.07.001_bib41","doi-asserted-by":"crossref","first-page":"332ra43","DOI":"10.1126\/scitranslmed.aad9982","article-title":"Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans","volume":"8","author":"Castillo","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.det.2016.07.001_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/exd.12826","article-title":"Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS)","volume":"25","author":"Vahidnezhad","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib43","unstructured":"Eng C. PTEN hamartoma tumor syndrome (PHTS). In: Pagon RA, Adam MP, Ardinger HH, et al, editors. Seattle (WA): GeneReviews(R); \u00a9 1993\u20132016 University of Washington, (http:\/\/www.genereviews.org\/) Initial Posting: November 29, 2001; Last Update: June 2, 2016."},{"key":"10.1016\/j.det.2016.07.001_bib44","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jnci\/djt277","article-title":"Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria","volume":"105","author":"Pilarski","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.det.2016.07.001_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/hmg\/7.3.507","article-title":"Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation","volume":"7","author":"Marsh","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.det.2016.07.001_bib46","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/hmg\/8.8.1461","article-title":"PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome","volume":"8","author":"Marsh","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.det.2016.07.001_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.clindermatol.2010.09.012","article-title":"Blaschko lines and other patterns of cutaneous mosaicism","volume":"29","author":"Molho-Pessach","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib48","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/archderm.1997.03890480025004","article-title":"A\u00a0rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity","volume":"133","author":"Happle","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1590\/abd1806-4841.20132015","article-title":"Cutaneous mosaicisms: concepts, patterns and classifications","volume":"88","author":"Kouzak","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib50","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/cge.12078","article-title":"PTEN mosaicism with features of Cowden syndrome","volume":"84","author":"Gammon","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.det.2016.07.001_bib51","first-page":"133","article-title":"Linear Cowden nevus: a new distinct epidermal nevus","volume":"17","author":"Happle","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib52","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/PAS.0b013e31824dd86c","article-title":"PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes","volume":"36","author":"Kurek","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.det.2016.07.001_bib53","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.det.2016.07.001_bib54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/138920208786241243","article-title":"Genetics and molecular biology of tuberous sclerosis complex","volume":"9","author":"Napolioni","year":"2008","journal-title":"Curr Genomics"},{"key":"10.1016\/j.det.2016.07.001_bib55","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.det.2016.07.001_bib56","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jid.2015.11.015","article-title":"Nipple angiofibromas with loss of TSC2 are associated with tuberous sclerosis complex","volume":"136","author":"Nathan","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib57","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamadermatol.2014.938","article-title":"Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements","volume":"150","author":"Teng","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib58","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2006.11.019","article-title":"Oral findings in 58 adults with tuberous sclerosis complex","volume":"56","author":"Sparling","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib59","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.det.2016.07.001_bib60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00439-006-0308-9","article-title":"Identification of 54 large deletions\/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations","volume":"121","author":"Kozlowski","year":"2007","journal-title":"Hum Genet"},{"key":"10.1016\/j.det.2016.07.001_bib61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","article-title":"Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States","volume":"9","author":"Au","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.det.2016.07.001_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fcell.2014.00069","article-title":"The neural crest lineage as a driver of disease heterogeneity in tuberous sclerosis complex and lymphangioleiomyomatosis","volume":"2","author":"Delaney","year":"2014","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.det.2016.07.001_bib63","first-page":"284","article-title":"Unilateral facial angiofibromas without other evidence of tuberous sclerosis: case report and review of the literature","volume":"80","author":"Hall","year":"2007","journal-title":"Cutis"},{"issue":"12","key":"10.1016\/j.det.2016.07.001_bib64","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/dmcn.12523","article-title":"Absence of subependymal nodules in patients with tubers suggests possible neuroectodermal mosaicism in tuberous sclerosis complex","volume":"56","author":"Boronat","year":"2014","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.det.2016.07.001_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cge.12245","article-title":"Tuberous sclerosis complex without tubers and subependymal nodules: a phenotype-genotype study","volume":"86","author":"Boronat","year":"2014","journal-title":"Clin Genet"},{"issue":"9","key":"10.1016\/j.det.2016.07.001_bib66","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jamadermatol.2013.10368","article-title":"A\u00a0limited form of proteus syndrome with bilateral plantar cerebriform collagenomas and varicose veins secondary to a mosaic AKT1 mutation","volume":"150","author":"Wee","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/jid.2013.312","article-title":"AKT1 gene mutation levels are correlated with the type of dermatologic lesions in patients with Proteus syndrome","volume":"134","author":"Lindhurst","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib68","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.0712397105","article-title":"Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.det.2016.07.001_bib69","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/hmg\/ddt597","article-title":"Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex","volume":"23","author":"Tyburczy","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.det.2016.07.001_bib70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ajmg.a.35764","article-title":"High-level somatic mosaicism of AKT1 c.49G>A mutation in skin scrapings from epidermal nevi enables non-invasive molecular diagnosis in patients with Proteus syndrome","volume":"161A","author":"Wieland","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.det.2016.07.001_bib71","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","article-title":"Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype\u2013phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex","volume":"13","author":"Sancak","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.det.2016.07.001_bib72","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/ajmg.a.36454","article-title":"Segmental overgrowth syndrome due to an activating PIK3CA mutation identified in affected muscle tissue by exome sequencing","volume":"164A","author":"Rasmussen","year":"2014","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.det.2016.07.001_bib73","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2340\/00015555-2203","article-title":"The adult phenotype of tuberous sclerosis complex in men","volume":"96","author":"Nathan","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2016.07.001_bib74","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.det.2016.07.001_bib75","first-page":"1201","article-title":"Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features","volume":"149","author":"Bjornsson","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.det.2016.07.001_bib76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajmg.c.30064","article-title":"Risk of tumorigenesis in overgrowth syndromes: a comprehensive review","volume":"137C","author":"Lapunzina","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.det.2016.07.001_bib77","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1096-8628(19981002)79:4<274::AID-AJMG8>3.0.CO;2-M","article-title":"Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review","volume":"79","author":"Hoyme","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.det.2016.07.001_bib78","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/GIM.0b013e31819436cf","article-title":"Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia","volume":"11","author":"Clericuzio","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.det.2016.07.001_bib79","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/ajmg.a.36651","article-title":"Activating PIK3CA somatic mutation in congenital unilateral isolated muscle overgrowth of the upper extremity","volume":"164A","author":"Castiglioni","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.det.2016.07.001_bib80","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaad.2015.07.018","article-title":"Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus","volume":"73","author":"Nathan","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib81","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/pr.2013.246","article-title":"Sirolimus treatment of severe PTEN hamartoma tumor syndrome: case report and in\u00a0vitro studies","volume":"75","author":"Schmid","year":"2014","journal-title":"Pediatr Res"},{"key":"10.1016\/j.det.2016.07.001_bib82","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaad.2015.01.014","article-title":"Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology","volume":"72","author":"Fogel","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.07.001_bib83","doi-asserted-by":"crossref","first-page":"e0123092","DOI":"10.1371\/journal.pone.0123092","article-title":"Molecular and functional characterization of three different postzygotic mutations in PIK3CA-related overgrowth spectrum (PROS) patients: effects on PI3K\/AKT\/mTOR signaling and sensitivity to PIK3 inhibitors","volume":"10","author":"Loconte","year":"2015","journal-title":"PLoS One"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863516300730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863516300730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T11:27:16Z","timestamp":1536233236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863516300730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0733863516300730"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2016.07.001","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mosaic Disorders of the PI3K\/PTEN\/AKT\/TSC\/mTORC1 Signaling Pathway","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}